Gossamer Bio
GOSS
GOSS
98 hedge funds and large institutions have $197M invested in Gossamer Bio in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4.06% more ownership
Funds ownership: 91.23% → 95.29% (+4.1%)
3% more funds holding
Funds holding: 95 → 98 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
98
Holding in Top 10
1
Calls
$3.18M
Puts
$936K
Top Buyers
| 1 | +$10.6M | |
| 2 | +$9.81M | |
| 3 | +$5.16M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.46M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.37M |
Top Sellers
| 1 | -$5.41M | |
| 2 | -$5.19M | |
| 3 | -$4.94M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.55M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.78M |